Open AccessCystatin C as risk factor for cardiovascular events and all-cause mortality in the general population. The Tromsø Study
Author(s) -
Ingrid Toft,
Marit D. Solbu,
Jens Kronborg,
Ulla Dorte Mathisen,
Bjørn O. Eriksen,
Hilde M. Storhaug,
Toralf Melsom,
MajaLisa Løchen,
Ellisiv B. Mathiesen,
Inger Njølstad,
Tom Wilsgaard,
Jan Brox
Publication year - 2011
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfr751
Subject(s) - medicine , cystatin c , renal function , creatinine , risk factor , prospective cohort study , population , cardiology , environmental health
Glomerular filtration rate<60 mL/min/1.73 m2 is associated with increased cardiovascular risk. Cystatin C is believed to be a better tool than creatinine for detection of mild renal dysfunction (>60 mL/min/1.73 m2) and possibly a more sensitive marker for cardiovascular risk and all-cause mortality. We examined the association of cystatin C with cardiovascular morbidity and all-cause mortality in a prospective population-based study.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom